WNS (WNS) Competitors

WNS (NYSE:WNS) and Medpace (NASDAQ:MEDP) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

Is WNS or MEDP more profitable?

Medpace has a net margin of 19.17% compared to WNS's net margin of 10.03%. Medpace's return on equity of 51.48% beat WNS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WNS	10.03%	22.25%	11.58%
Medpace	19.17%	51.48%	20.47%

Does the media refer more to WNS or MEDP?

In the previous week, Medpace had 7 more articles in the media than WNS. MarketBeat recorded 12 mentions for Medpace and 5 mentions for WNS. Medpace's average media sentiment score of 0.84 beat WNS's score of 0.32 indicating that Medpace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
WNS	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Medpace	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, WNS or MEDP?

Medpace has higher revenue and earnings than WNS. WNS is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WNS	$1.32B	1.94	$140.15M	$2.86	19.38
Medpace	$2.11B	4.92	$404.39M	$12.63	26.98

Which has more risk and volatility, WNS or MEDP?

WNS has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500.

Do insiders & institutionals believe in WNS or MEDP?

97.4% of WNS shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 2.0% of WNS shares are owned by insiders. Comparatively, 20.3% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Do analysts rate WNS or MEDP?

WNS currently has a consensus price target of $61.00, suggesting a potential upside of 10.05%. Medpace has a consensus price target of $381.44, suggesting a potential upside of 11.93%. Given Medpace's higher possible upside, analysts clearly believe Medpace is more favorable than WNS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WNS	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.63
Medpace	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

Does the MarketBeat Community favor WNS or MEDP?

WNS received 179 more outperform votes than Medpace when rated by MarketBeat users. Likewise, 72.54% of users gave WNS an outperform vote while only 63.54% of users gave Medpace an outperform vote.

Company	Underperform	Outperform
WNS	Outperform Votes 531 72.54%	Underperform Votes 201 27.46%
Medpace	Outperform Votes 352 63.54%	Underperform Votes 202 36.46%

Summary

Medpace beats WNS on 13 of the 17 factors compared between the two stocks.